期刊文献+

幽门螺杆菌治疗适应证与评价

原文传递
导出
摘要 有关幽门螺杆菌(Helicobacter pylori,Hp)治疗的适应证随着学者们对Hp致病的不断深入了解,对Hp发病机制和病理生理的深入研究,Hp耐药菌株的出现,在治疗上也随着认识的提高,强调个体化治疗,使得Hp治疗的适应证和治疗方案也不断更新。
作者 池肇春
出处 《中国医师进修杂志》 2014年第7期6-8,共3页 Chinese Journal of Postgraduates of Medicine
  • 相关文献

参考文献1

二级参考文献24

  • 1Wotherspoon AC,Ortiz-Hidalgo C,Falzon MR,Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991; 338: 1175-1176.
  • 2Parsonnet J,Hansen S,Rodriguez L,Gelb AB,Warnke RA, Jellum E,Orentreich N,Vogelman JH,Friedman GD. He- licobacter pylori infection and gastric lymphoma. N Engl J Med 1994; 330: 1267-1271.
  • 3Eck M,Schmausser B,Haas R,Greiner A,Czub S,Müller- Hermelink HK. MALT-type lymphoma of the stomach is associated with Helicobacter pylori strains expressing the CagA protein. Gastroenterology 1997; 112: 1482-1486.
  • 4Sagaert X,Van Cutsem E,De Hertogh G,Geboes K, Tousseyn T. Gastric MALT lymphoma: a model of chronic inflammation-induced tumor development. Nat Rev Gastro- enterol Hepatol 2010; 7: 336-346.
  • 5Bonizzi G,Karin M. The two NF-kappaB activation path- ways and their role in innate and adaptive immunity. Trends Immunol 2004; 25: 280-288.
  • 6Zullo A,Hassan C,Andriani A,Cristofari F,De Francesco V, Ierardi E,Tomao S,Morini S,Vaira D. Eradication therapy for Helicobacter pylori in patients with gastric MALT lym- phoma: a pooled data analysis. Am J Gastroenterol 2009; 104: 1932-1937; quiz 1938.
  • 7Zucca E,Dreyling M. Gastric marginal zone lymphoma of MALT type: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2008; 19 Suppl 2: ii70- ii71.
  • 8Ye H,Liu H,Attygalle A,Wotherspoon AC,Nicholson AG, Charlotte F,Leblond V,Speight P,Goodlad J,Lavergne- Slove A,Martin-Subero JI,Siebert R,Dogan A,Isaacson PG, Du MQ. Variable frequencies of t(11; 18)(q21; q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphoma. Blood 2003; 102: 1012-1018.
  • 9Alpen B,Neubauer A,Dierlamm J,Marynen P,Thiede C, Bayerd rfer E,Stolte M. Translocation t(11; 18) absent in early gastric marginal zone B-cell lymphoma of MALT type responding to eradication of Helicobacter pylori infection. Blood 2000; 95: 4014-4015.
  • 10Sugiyama T,Asaka M,Nakamura T,Nakamura S,Yonezu- mi S,Seto M. API2-MALT1 chimeric transcript is a predic- tive marker for the responsiveness of H. pylori eradication treatment in low-grade gastric MALT lymphoma. Gastroen- terology 2001; 120: 1884-1885.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部